Survival and Risk Factor for Mortality of Infants with Trisomy-21 and Pulmonary Hypertension: A Population-Based Study from a Middle-Income Country
Pediatric Cardiology · 2026
DOI: 10.1007/s00246-024-03732-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Cardiology, 2026. Verfasst von Mohd Nizam Mat Bah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Ministry of Health Malaysia, Hospital Sultanah Aminah, Persiaran Abu Bakar Sultan, 80100, Johor Bahru, Johor DT, Malaysia. …. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Down Syndrome. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Limited studies are available on the outcome of infants with trisomy-21 and pulmonary hypertension (PHT) in lower- and middle-income countries. This population-based cohort study aims to determine the outcome and survival from birth to 5 years of infants with trisomy-21 and PHT born between 2016 and 2021. The mortality rate and Kaplan-Meier survival analysis were calculated to assess survival rates at 1 and 5 years. Multivariate Cox regression analysis was used to examine mortality-related factors. A total of 488 trisomy-21 infants were identified, with 176 (36%) having PHT and 245 (50%) having congenital heart disease (CHD). Of 176 PHT, 74 (42%) had moderate to severe PHT, and 115 (65%) patients had their PHT resolved at a median age of 7 weeks (Interquartile range [IQR]: 3 to 16.8 weeks), and 48 (27%) died at a median age of 3.6 months (IQR: 0.6 to 7.1 months). The survival at 1 and 5 years was 74% and 71%, respectively. The independent factors for mortality were infants with birth weight less than 2.5 kg (adjusted Hazard Ratio [aHR] 2.1 95% confidence interval [CI] 1.1-4.2, p = .02), symptomatic infants (aHR 3.3 95% CI 1.4-7.6, p = .006), late-onset PHT (aHR 3.8 95% CI 1.6-8.9, p = .002), with CHD (aHR 2.1 95% CI 1.1-4.2, p = .03) and those with Persistent Pulmonary Hypertension of Newborn [PPHN] (aHR 2.1 95% CI 1.0-4.3, p = .047). One-third of infants with trisomy-21 experienced PHT, with seven out of ten surviving until age five. Those with low birth weight, symptomatic infants, CHD, late-onset PHT, and PPHN were associated with low survival rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Ministry of Health Malaysia, Hospital Sultanah Aminah, Persiaran Abu Bakar Sultan, 80100, Johor Bahru, Johor DT, Malaysia. nurnizam95@gmail.com.
- Department of Pediatrics, Faculty of Medicine, University of Malaya, Lembah Pantai, Kuala Lumpur, Malaysia.
- Department of Pediatrics, Ministry of Health Malaysia, Hospital Sultanah Aminah, Persiaran Abu Bakar Sultan, 80100, Johor Bahru, Johor DT, Malaysia.
ORCID-Profile: Mohd Nizam Mat Bah
Zitieren
APA
Mat Bah, M. N., Zahari, N., Abdullah, N. A., Sapian, M. H., & Alias, E. Y. (2026). Survival and Risk Factor for Mortality of Infants with Trisomy-21 and Pulmonary Hypertension: A Population-Based Study from a Middle-Income Country. Pediatric Cardiology. https://doi.org/10.1007/s00246-024-03732-1
Vancouver
Mat Bah MN, Zahari N, Abdullah NA, Sapian MH, Alias EY. Survival and Risk Factor for Mortality of Infants with Trisomy-21 and Pulmonary Hypertension: A Population-Based Study from a Middle-Income Country. Pediatric Cardiology. 2026. doi:10.1007/s00246-024-03732-1
BibTeX
@article{MatBah2026,
author = {Mat Bah, Mohd Nizam and Zahari, Norazah and Abdullah, Noor Adibah and Sapian, Mohd Hanafi and Alias, Emieliyuza Yusnita},
title = {Survival and Risk Factor for Mortality of Infants with Trisomy-21 and Pulmonary Hypertension: A Population-Based Study from a Middle-Income Country},
journal = {Pediatric Cardiology},
year = {2026},
doi = {10.1007/s00246-024-03732-1}
}
EUVIMED